Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Feb 8;10(4):648.
doi: 10.3390/jcm10040648.

Malignant Pleural Mesothelioma: Time Is Running Out

Filippo Lococo  1   2
Affiliations
Editorial

Malignant Pleural Mesothelioma: Time Is Running Out

Filippo Lococo. J Clin Med. .

Abstract

Malignant pleural mesothelioma (MPM) is a rare but highly malignant disease of the pleura usually related to asbestos exposure [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Robinson B.W., Musk A.W., Lake R.A. Malignant mesothelioma. Lancet. 2005;366:397–408. doi: 10.1016/S0140-6736(05)67025-0. - DOI - PubMed
    1. Hodgson J.T., McElvenny D.M., Darnton A.J., Price M.J., Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br. J. Cancer. 2005;92:587–593. doi: 10.1038/sj.bjc.6602307. - DOI - PMC - PubMed
    1. Scherpereel A., Astoul P., Baas P., Berghmans T., Clayson H., De Vuyst P., Dienemann H., Galateau-Salle F., Hennequin C., Hillerdal G., et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur. Respir. J. 2009;35:479–495. doi: 10.1183/09031936.00063109. - DOI - PubMed
    1. Arnold D.T., De Fonseka D., Hamilton F.W., Rahman N.M., Maskell N.A. Prognostication and monitoring of mesothelioma using biomarkers: A systematic review. Br. J. Cancer. 2017;116:731–741. doi: 10.1038/bjc.2017.22. - DOI - PMC - PubMed
    1. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 2003;21:2636–2644. doi: 10.1200/JCO.2003.11.136. - DOI - PubMed

Publication types

LinkOut - more resources